News about Industrial talks

India announces collaboration with Australia for Covid-19

India announces collaboration with Australia for Covid-19

Prime Minister Narendra Modi and the Prime Minister of Australia, Scott Morrison MP, announced a COVID-19 collaboration in 2020 during an India-Australia leaders? virtual summit held on June 4, 2020

Industrial talks | 08/06/2020 | By Darshana

NPPA issues list of revised MRPs to ensure compliance on price of N- 95 mask

NPPA issues list of revised MRPs to ensure compliance on price of N- 95 mask

To ensure the availability of N-95 masks at the revised MRPs as per price control compliance, the National Pharmaceutical Pricing Authority (NPPA) has issued a list of price reduction in N-95 masks by four major N-95 mask manufacturers, namely Venus Safety and Health Pvt Ltd, Magnum Health and Safety, Yash Care Life Sciences and Joseph Leslie & Co

Industrial talks | 08/06/2020 | By Darshana

Glenmark Pharma to study potential Covid-19 drug combination

Glenmark Pharma to study potential Covid-19 drug combination

Glenmark Pharmaceuticals Ltd said on Tuesday it would begin a clinical trial in India to test a combination of two anti-viral drugs, favipiravir and umifenovir, as a potential COVID-19 treatment

Industrial talks | 26/05/2020 | By Darshana

Bayer submits larotrectinib for marketing authorization in Japan for the treatment of TRK fusion cancer

Bayer submits larotrectinib for marketing authorization in Japan for the treatment of TRK fusion cancer

Bayer has submitted an application for marketing authorization for its precision oncology treatment larotrectinib to the Ministry of Health, Labor and Welfare (MHLW) in Japan. Larotrectinib is an oral TRK inhibitor that has been developed specifically to treat adults and children

Industrial talks | 25/05/2020 | By Darshana

Lupin?s Pithampur Unit-1 facility receives EIR from U.S. FDA

Lupin?s Pithampur Unit-1 facility receives EIR from U.S. FDA

Pharma major Lupin Limited (Lupin) today announced the receipt of the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for its Pithampur Unit-1, India facility. The inspection for the facility was conducted by the U.S. FDA between February 3, 2020 and February 11, 2020

Industrial talks | 30/04/2020 | By Darshana

Virtual Show: new technologies for solid dosage forms from Syntegon

Virtual Show: new technologies for solid dosage forms from Syntegon

From May 7 to 13, Syntegon Technology showcases its long-standing processing and packaging expertise for solid dosage forms at the Virtual Show. The new Sepion coater series, which is available in six sizes, marks the beginning of the novelties

Industrial talks | 29/04/2020 | By Darshana

Bayer partners with Population Health Research Institute (PHRI) on global clinical research evaluating COVID-19 treatments

Bayer partners with Population Health Research Institute (PHRI) on global clinical research evaluating COVID-19 treatments

Bayer announced today its Canadian organization Bayer Inc., Mississauga, Ontario, will partner with the Population Health Research Institute (PHRI) in launching a major clinical research program aimed at identifying potential treatments against COVID-19

Industrial talks | 22/04/2020 | By Darshana

FDA Approves First Therapy for Treatment of Low-Grade Upper Tract Urothelial Cancer

FDA Approves First Therapy for Treatment of Low-Grade Upper Tract Urothelial Cancer

Today, the U.S. Food and Drug Administration approved Jelmyto (mitomycin gel), the first therapy to treat low-grade upper tract urothelial cancer (UTUC). Urothelial cancer is a cancer of the lining of the urinary system

Industrial talks | 16/04/2020 | By Darshana

Corornavirus lockdown: Govt Orders Smooth Movement of Medial Equipments, Medicines

Corornavirus lockdown: Govt Orders Smooth Movement of Medial Equipments, Medicines

The central government has issued urgent orders to ensure smooth movement of medicines and other medical equipment in hospitals across the country which remains under a lockdown to contain the spread of novel coronavirus infection

Industrial talks | 28/03/2020 | By Darshana

Insulin Gains New Pathway to Increased Competition: USA FDA

Insulin Gains New Pathway to Increased Competition: USA FDA

Today is a historic day and a landmark moment for patients with diabetes and other serious medical conditions, as insulin and certain other biologic drugs transition to a different regulatory pathway. This regulatory transition, mandated by Congress and implemented by the FDA, is incredibly important for patients

Industrial talks | 24/03/2020 | By Darshana 151

 
 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology